Friday, 21 Sep 2018

You are here

Plaquenil During Lupus Pregnancy Lessens Flares

A large cohort study of pregnant and non-pregnant women with systemic lupus erythematosus has shown that lupus flares are increased during pregnancy and in the 3  months follwing delivery.

Investigators studied 1349 patients in the Hopkins Lupus Cohort between 14–45 years of age. They assessed disease activity an its relationship to pregnancy, postpartum or non-pregnant/non-postpartum periods. Among the 1349 patients, there were 398 pregnancies in 304 patients.

They found a 59% increased rate of lupus flare (defined by global assessment) during pregnancy (HR: 1.59). 

The use of hydroxychloroquine (HCQ) during pregnancy influenced these outomces (compared with non-pregnant/non-postpartum periods):

  • More Flares without HCQ use (HR 1.83; 95% CI 1.34 to 2.45) and
  • Less Flares with HCQ use (HR 1.26; 95% CI 0.88 to 1.69) 

This study shows that HCQ during pregnancy lessens the risk of flare during and after pregnancy.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

An Association between GCA and IBD ?

A population based analysis from Israel suggests that giant cell arteritis (GCA) patients may be at increased risk for  inflammatory bowel diseases (IBD) mainly target.

This research was based on sporadic reports in the medical literature (http://bit.ly/2pnIPM0)

Breast Implant Study: More Worries or Not?

The Annals of Surgery reports on an anlaysis of FDA-mandated postmarket studies, including nearly 100,000 breast implant pprocedures, that showed silicone implants to be associated with higher rates of  Sjögren's syndrome, scleroderma, rheumatoid arthritis, stillbirth, and melanoma.

New Classification of Idiopathic Inflammatory Myopathies

Using an observational cohort analysis of patients in the French myositis network, researchers have proposed a new classification of idiopathic inflammatory myopathies (IIM) with four subgroups: dermatomyositis, inclusion body myositis, immune-mediated necrotizing myopathy, and antisynthetase syndrome.

Rsearchers set out to define a classification system for IIM based on phenotypic, biological, and immunologic criteria. 

Depression Increases Risk of Systemic Lupus Erythematosus

Twenty-year data from the Nurses’ Health Study (NHS) suggests that depression is associated with a 2-fold increased frequency of systemic lupus erythematosus (SLE) - the question is why?

Interferon Blocker Disappoints in SLE

Yet another setback has occurred in the efforts to develop new medications for treating systemic lupus erythematosus (SLE), as anifrolumab failed to meet the primary endpoint in a phase III trial, according to AstraZeneca and MedImmune.